{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:29:14Z","timestamp":1793089754568,"version":"4.5.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T00:00:00Z","timestamp":1519603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0193477","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T18:32:56Z","timestamp":1519669976000},"page":"e0193477","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8665-0546","authenticated-orcid":true,"given":"Damien","family":"Ambrosetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maeva","family":"Dufies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9reng\u00e8re","family":"Dadone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Borchiellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Amiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Pouyssegur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Rioux-Leclercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Pages","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Burel-Vandenbos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie M.","family":"Mazure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,2,26]]},"reference":[{"issue":"7","key":"ref1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00000478-198210000-00007","article-title":"Prognostic significance of morphologic parameters in renal cell carcinoma","volume":"6","author":"SA Fuhrman","year":"1982","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrc3844","article-title":"VHL, the story of a tumour suppressor gene","volume":"15","author":"L Gossage","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"23","key":"ref3","doi-asserted-by":"crossref","first-page":"7081","DOI":"10.1128\/MCB.00773-08","article-title":"Hypoxia-associated factor, a novel E3-ubiquitin ligase, binds and ubiquitinates hypoxia-inducible factor 1alpha, leading to its oxygen-independent degradation","volume":"28","author":"MY Koh","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1158\/0008-5472.CAN-10-4142","article-title":"The hypoxia-associated factor switches cells from HIF-1alpha- to HIF-2alpha-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion","volume":"71","author":"MY Koh","year":"2011","journal-title":"Cancer Res"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc3183","article-title":"HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression","volume":"12","author":"B Keith","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.5489\/cuaj.10196","article-title":"Metabolic features of clear-cell renal cell carcinoma: mechanisms and clinical implications","volume":"5","author":"JH Pinthus","year":"2011","journal-title":"Can Urol Assoc J"},{"issue":"46","key":"ref7","doi-asserted-by":"crossref","first-page":"32631","DOI":"10.1074\/jbc.274.46.32631","article-title":"p42\/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1","volume":"274","author":"DE Richard","year":"1999","journal-title":"J Biol Chem"},{"issue":"40","key":"ref8","doi-asserted-by":"crossref","first-page":"16663","DOI":"10.1073\/pnas.1106123108","article-title":"CD147 subunit of lactate\/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors","volume":"108","author":"R Le Floch","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","article-title":"Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer","volume":"17","author":"JM Harvey","year":"1999","journal-title":"J Clin Oncol"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ejca.2008.01.008","article-title":"Wilms' tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis","volume":"44","author":"T Sera","year":"2008","journal-title":"Eur J Cancer"},{"issue":"2","key":"ref11","first-page":"802","article-title":"Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy","volume":"9","author":"MH Bui","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"269","key":"ref12","first-page":"pl1","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"J Gao","year":"2013","journal-title":"Sci Signal"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"E Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"5","key":"ref14","first-page":"1164","article-title":"Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers","volume":"56","author":"M Younes","year":"1996","journal-title":"Cancer Res"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1464-410X.2007.07238.x","article-title":"Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha","volume":"101","author":"A Lidgren","year":"2008","journal-title":"BJU Int"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1309\/HV6NJVRQKK4QHM9F","article-title":"Expression of GLUT1 in primary renal tumors: morphologic and biologic implications","volume":"128","author":"A Ozcan","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"30","key":"ref17","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1200\/JCO.2007.12.1087","article-title":"Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma","volume":"25","author":"BC Leibovich","year":"2007","journal-title":"J Clin Oncol"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1464-410X.2007.07006.x","article-title":"Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma","volume":"100","author":"J Sandlund","year":"2007","journal-title":"BJU Int"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/sj.bjc.6605839","article-title":"Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression","volume":"103","author":"J Hao","year":"2010","journal-title":"Br J Cancer"},{"issue":"7","key":"ref20","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1365-2559.2010.03560.x","article-title":"Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma","volume":"56","author":"C Pinheiro","year":"2010","journal-title":"Histopathology"},{"issue":"4","key":"ref21","first-page":"916","article-title":"High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers","volume":"60","author":"S Walenta","year":"2000","journal-title":"Cancer Res"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.humpath.2014.09.013","article-title":"Expression of lactate\/H(+) symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses","volume":"46","author":"Y Kim","year":"2015","journal-title":"Hum Pathol"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/PGP.0b013e31817b5b40","article-title":"Increasing expression of monocarboxylate transporters 1 and 4 along progression to invasive cervical carcinoma","volume":"27","author":"C Pinheiro","year":"2008","journal-title":"Int J Gynecol Pathol"},{"issue":"13","key":"ref24","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1128\/MCB.25.13.5675-5686.2005","article-title":"Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma","volume":"25","author":"RR Raval","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"24","key":"ref25","doi-asserted-by":"crossref","first-page":"7388","DOI":"10.1158\/1078-0432.CCR-07-0411","article-title":"Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma","volume":"13","author":"T Klatte","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"2","key":"ref26","first-page":"162","article-title":"Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?","volume":"1795","author":"S Kaluz","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"ref27","first-page":"995","article-title":"Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells","volume":"24","author":"M Rafajova","year":"2004","journal-title":"Int J Oncol"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1200\/JCO.2007.15.8345","article-title":"Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma","volume":"27","author":"T Klatte","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/sj.onc.1208305","article-title":"Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma","volume":"24","author":"BL Petrella","year":"2005","journal-title":"Oncogene"},{"issue":"15","key":"ref30","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1093\/emboj\/cdf411","article-title":"CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain","volume":"21","author":"H Mori","year":"2002","journal-title":"EMBO J"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1158\/0008-5472.CAN-13-2190","article-title":"Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinoma","volume":"75","author":"MY Koh","year":"2015","journal-title":"Cancer Res"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.bbabio.2010.10.012","article-title":"Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma?","volume":"1807","author":"C Jose","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.bbrc.2015.03.130","article-title":"Metabolic signatures of renal cell carcinoma","volume":"460","author":"HY Lim","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"ref34","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/ncb3039","article-title":"PGC-1\u03b1 mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis","volume":"16","author":"VS LeBleu","year":"2014","journal-title":"Nat Cell Biol"},{"issue":"7","key":"ref35","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1158\/0008-5472.CAN-16-2074","article-title":"Modeling the Genetic Regulation of Cancer Metabolism: Interplay between Glycolysis and Oxidative Phosphorylation","volume":"77","author":"L Yu","year":"2017","journal-title":"Cancer Res"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/sj.bjc.6603796","article-title":"High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile","volume":"96","author":"MM Baldewijns","year":"2007","journal-title":"Br J Cancer"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/cncr.10433","article-title":"pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival","volume":"94","author":"JC Cheville","year":"2002","journal-title":"Cancer"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0193477","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T15:29:16Z","timestamp":1719847756000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0193477"}},"subtitle":[],"editor":[{"given":"Pankaj K.","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,2,26]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0193477","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,26]]}}}